Safety and efficacy of immune-stimulating complex-based antigen delivery systems for neonatal immunisation against respiratory syncytial virus infection

Microbes and Infection

Volumn 6, Issue 7, 2004, Pages 666-675

  Regner, Matthias ^a   Culley, Fiona ^b   Fontannaz, Paola ^a   Hu, Kefei ^c   Morein, Bror ^c   Lambert, Paul Henri ^a   Openshaw, Peter ^b   Siegrist, Claire Anne ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

BAL; bronchoalveolar lavage; cytotoxic T; F; fusion; G; glyco; hRSV; human Respiratory syncytial virus; immune stimulating complex; ISCOM; ISCOMs; Neonate; precursor cytotoxic T; pTc; Respiratory syncytial virus; T helper; Tc; Th; Vaccines

Indexed keywords

INTERLEUKIN 4; ISCOM; ISCOM A; MEMBRANE PROTEIN; RESPIRATORY SYNCYTIAL VIRUS VACCINE; SAPONIN; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS PROTEIN;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BRONCHIOLITIS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG POTENCY; DRUG SAFETY; DRUG TARGETING; IMMUNIZATION; LOEFFLER PNEUMONIA; LUNG ALVEOLUS CELL; MOUSE; NEWBORN; NEWBORN CARE; NEWBORN PERIOD; NONHUMAN; PRIORITY JOURNAL; QUILLAJA; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TRANSIENT ILLNESS; VIRUS INFECTION; WEIGHT REDUCTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; BRONCHIOLITIS, VIRAL; HUMANS; IMMUNIZATION; ISCOMS; MICE; MICE, INBRED BALB C; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SAPONINS; T-LYMPHOCYTES;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; QUILLAJA; RESPIRATORY SYNCYTIAL VIRUS;

EID: 2442693774     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2004.03.005     Document Type: Article

References (39)

1. Glezen P., Denny F.W. Epidemiology of acute lower respiratory disease in children. N. Engl. J. Med. 288:1973;498-505
2. Openshaw P.J. Immunopathological mechanisms in respiratory syncytial virus disease. Springer Semin. Immunopathol. 17:1995;187-201
3. Kim H.W., Leikin S.L., Arrobio J., Brandt C.D., Chanock R.M., Parrott R.H. Cell-mediated immunity to respiratory syncytial virus induced by inactivated vaccine or by infection. Pediatr. Res. 10:1976;75-78
4. Kaipikian A.Z., Mitchell R.H., Chanock R.M., Shvedoff R.A., Stewart C.E. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89:1969;405
5. + T cells. J. Virol. 66:1992;7444-7451
6. Openshaw P.J., Culley F.J., Olszewska W. Immunopathogenesis of vaccine-enhanced RSV disease. Vaccine. 20:(Suppl 1):2001;S27-S31
7. Cannon M.J., Openshaw P.J., Askonas B.A. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 168:1988;1163-1168
8. +T cells during infection with respiratory syncytial virus are mediated by IFN-gamma. Eur. J. Immunol. 32:2002;2117-2123
9. Hussell T., Baldwin C.J., O'Garra A., Openshaw P.J. CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur. J. Immunol. 27:1997;3341-3349
10. Waris M.E., Tsou C., Erdman D.D., Day D.B., Anderson L.J. Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV. J. Virol. 71:1997;6935-6939
11. Culley F.J., Pollott J., Openshaw P.J. Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J. Exp. Med. 196:2002;1381-1386
12. Kersten G.F., Spiekstra A., Beuvery E.C., Crommelin D.J. On the structure of immune-stimulating saponin-lipid complexes (iscoms). Biochim. Biophys. Acta. 1062:1991;165-171
13. Morein B., Bengtsson K.L. Immunomodulation by iscoms, immune stimulating complexes. Methods. 19:1999;94-102
14. Hu K.F., Elvander M., Merza M., Akerblom L., Brandenburg A., Morein B. The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses. Clin. Exp. Immunol. 113:1998;235-243
15. Chen M., Hu K.F., Rozell B., Orvell C., Morein B., Liljestrom P. Vaccination with recombinant alphavirus or immune-stimulating complex antigen against respiratory syncytial virus. J. Immunol. 169:2002;3208-3216
16. Siegrist C.A. Neonatal and early life vaccinology. Vaccine. 19:2001;3331-3346
17. Hu K.F., Ekstrom J., Merza M., Lovgren-Bengtsson K., Morein B. Induction of antibody responses in the common mucosal immune system by respiratory syncytical virus immunostimulating complexes. Med. Microbiol. Immunol. (Berl). 187:1999;191-198
18. Barrios C., Brawand P., Berney M., Brandt C., Lambert P.H., Siegrist C.A. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur. J. Immunol. 26:1996;1489-1496
19. Chang J., Srikiatkhachorn A., Braciale T.J. Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection. J. Immunol. 167:2001;4254-4260
20. Hussell T., Spender L.C., Georgiou A., O'Garra A., Openshaw P.J. Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virus. J. Gen. Virol. 77:(Pt 10):1996;2447-2455
21. Tripp R.A., Anderson L.J. Cytotoxic T-lymphocyte precursor frequencies in BALB/c mice after acute respiratory syncytial virus (RSV) infection or immunization with a formalin-inactivated RSV vaccine. J. Virol. 72:1998;8971-8975
22. Kovarik J., Martinez X., Pihlgren M., Bozzotti P., Tao M.H., Kipps T.J., Wild T.F., Lambert P.H., Siegrist C.A. Limitations of in vivo IL-12 supplementation strategies to induce Th1 early life responses to model viral and bacterial vaccine antigens. Virology. 268:2000;122-131
23. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., Walsh E.E., Freeman M.W., Golenbock D.T., Anderson L.J., Finberg R.W. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1:2000;398-401
24. Ostler T., Ehl S. Pulmonary T cells induced by respiratory syncytial virus are functional and can make an important contribution to long-lived protective immunity. Eur. J. Immunol. 32:2002;2562-2569
25. Martinez X., Regner M., Kovarik J., Zarei S., Hauser C., Lambert P.H., Leclerc C., Siegrist C.A. CD4-independent protective cytotoxic T cells induced in early life by a non-replicative delivery system based on virus-like particles. Virology. 305:2003;428-435
26. Zhang J., Silvestri N., Whitton J.L., Hassett D.E. Neonates mount robust and protective adult-like CD8(+)-T-cell responses to DNA vaccines. J. Virol. 76:2002;11911-21199
27. Vekemans J., Truyens C., Torrico F., Solano M., Torrico M.C., Rodriguez P., Alonso-Vega C., Carlier Y. Maternal Trypanosoma cruzi infection upregulates capacity of uninfected neonate cells To produce pro- and anti-inflammatory cytokines. Infect. Immun. 68:2000;5430-5434
28. Marchant A., Appay V., Van Der Sande M., Dulphy N., Liesnard C., Kidd M., Kaye S., Ojuola O., Gillespie G.M., Vargas Cuero A.L., Cerundolo V., Callan M., McAdam K.P., Rowland-Jones S.L., Donner C., McMichael A.J., Whittle H. Mature CD8(+) T lymphocyte response to viral infection during fetal life. J. Clin. Invest. 111:2003;1747-1755
29. Sparer T.E., Matthews S., Hussell T., Rae A.J., Garcia-Barreno B., Melero J.A., Openshaw P.J. Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia. J. Exp. Med. 187:1998;1921-1926
30. Tripp R.A., Jones L.P., Haynes L.M., Zheng H., Murphy P.M., Anderson L.J. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat. Immunol. 2:2001;732-738
31. Srikiatkhachorn A., Braciale T.J. Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection. J. Virol. 71:1997;678-685
32. Openshaw P.J., Clarke S.L., Record F.M. Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. Int. Immunol. 4:1992;493-500
33. Alwan W.H., Kozlowska W.J., Openshaw P.J. Distinct types of lung disease caused by functional subsets of antiviral T cells. J. Exp. Med. 179:1994;81-89
34. Durbin J.E., Johnson T.R., Durbin R.K., Mertz S.E., Morotti R.A., Peebles R.S., Graham B.S. The role of IFN in respiratory syncytial virus pathogenesis. J. Immunol. 168:2002;2944-2952
35. van Schaik S.M., Obot N., Enhorning G., Hintz K., Gross K., Hancock G.E., Stack A.M., Welliver R.C. Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice. J. Med. Virol. 62:2000;257-266
36. Plotnicky-Gilquin H., Cyblat-Chanal D., Aubry J.P., Champion T., Beck A., Nguyen T., Bonnefoy J.Y., Corvaia N. Gamma interferon-dependent protection of the mouse upper respiratory tract following parenteral immunization with a respiratory syncytial virus G protein fragment. J. Virol. 76:2002;10203-10210
37. Barrios C., Brandt C., Berney M., Lambert P.H., Siegrist C.A. Partial correction of the TH2/TH1 imbalance in neonatal murine responses to vaccine antigens through selective adjuvant effects. Eur. J. Immunol. 26:1996;2666-2670
38. Plotnicky H., Siegrist C.A., Aubry J.P., Bonnefoy J.Y., Corvaia N., Nguyen T.N., Power U.F. Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate. Vaccine. 21:2003;2651-2660
39. Spender L.C., Hussell T., Openshaw P.J. Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease. J. Gen. Virol. 79:(Part 7):1998;1751-1758